×


Since 1992, Cambridge Healthtech Institute (CHI) has brought together the life science community to advance development of small molecule drugs, biologics and other therapeutic modalities. In the challenging environment of social distancing and quarantine, CHI, in the format of a series of interactive webinars, once again takes the leadership role of connecting the life science community by bringing you the latest research and technologies for new drug discovery and development. CHI’s Drug Discovery & Preclinical Webinar Series will feature cutting edge research starting from target identification and validation, to disease modeling, to non-clinical development of novel therapeutics. The webinars will be free for the drug discovery and development community around the world and will provide opportunities for virtual Q&A sessions, discussions and networking to keep us connected and informed in the current environment.


Sponsors


Platinum Sponsor

NanotemperTechnologies




Webinar Proposals


Formulation and Stability Screening of Biotherapeutics

SEPTEMBER 23, 2020Program | Register | Sponsored by: Nanotemper

Charles Heffern
Product Manager, NanoTemper

Jie Wen
Senior Scientist, Higher Order Structure, Biological Relevance and Characterization, Attribute Sciences Amgen, Thousand Oaks


Researching and Targeting Tumor Microenvironment: New Frontline in Immuno-Oncology Research

SEPTEMBER 30, 2020Program | Register | Sponsored by: AIM Biotech MilliporeSigma

Russell W. Jenkins, MD, PhD
Assistant Professor
Dept. of Medicine, Center for Cancer Research, Massachusetts General Hospital

Viviana Cremasco, PhD
Investigator III, Exploratory Immuno-Oncology
Novartis

Pushpa Jayaraman, PhD
Senior Investigator I, Exploratory Immuno-Oncology
Novartis Institutes for Biomedical Research

Chairperson: Kuan Chee Mun
CEO
AIM Biotech


The Role of 3D in the Fight Against SARS-CoV-2: Using Organoids for COVID-19 Disease Models and Organoid Best Practices

OCTOBER 21, 2020Program | Register | Sponsored by: Corning Life Sciences

Shuibing Chen, PhD
Kilts Family Associate Professor, Director of Diabetes Program, Department of Surgery
Weill Cornell Medicine

Austin Mogen, PhD
Senior Field Application Scientist
Corning Life Sciences


ACCELERATING TARGET DISCOVERY

CRISPR and Functional Genomics

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Chemoproteomics Enabling Drug Discovery

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Practical Phenotypic Screening

Date to be Announced
Submit Proposal | Sponsor | Request More Info

PROTACs and Protein Degradation

Date to be Announced
Submit Proposal | Sponsor | Request More Info


AI for Target Discovery

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Emerging Viral and Host Targets for COVID-19

Date to be Announced
Submit Proposal | Sponsor | Request More Info

EXPANDING CHEMICAL & DRUGGABLE SPACE
Encoded Libraries & Macrocyclics

Date to be Announced
Submit Proposal | Sponsor | Request More Info


FBDD & Lead Generation

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Targeting RNA

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Immunology & Autoimmunity

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Targeting the Microbiome

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Gene and Cell Therapy

Date to be Announced
Submit Proposal | Sponsor | Request More Info

CNS Drug Discovery and Development Strategies

Date to be Announced
Submit Proposal | Sponsor | Request More Info

DISEASE MODELING
3D Cellular Modeling, Microphysiological Systems and Bioengineered Models

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Preclinical Models in Oncology and Immuno-Oncology

Date to be Announced
Submit Proposal | Sponsor | Request More Info

Drug Discovery Using iPSC-Derived Cells

Date to be Announced
Submit Proposal | Sponsor | Request More Info


ADVANCES IN DRUG METABOLISM & SAFETY TESTING
Optimizing Drug Metabolism, Drug Clearance and Drug-Drug Interactions

Date to be Announced
Submit Proposal | Sponsor | Request More Info


AI for Lead Optimization and Safety Predictions

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Evaluating and Characterizing in vitro Models of Drug Toxicity

Date to be Announced
Submit Proposal | Sponsor | Request More Info

PRECLINICAL AND NONCLINICAL STRATEGIES
Translational Biomarkers

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Delivery of Biologics and Immunotherapies

Date to be Announced
Submit Proposal | Sponsor | Request More Info

Formulation and Drug Delivery

Date to be Announced
Submit Proposal | Sponsor | Request More Info


IMMUNO-ONCOLOGY ADVANCES
Targeting Tumor Microenvironment and Inflammation

Date to be Announced
Submit Proposal | Sponsor | Request More Info


Adoptive Cell Therapy Strategies

Date to be Announced
Submit Proposal | Sponsor | Request More Info

Modeling for IO Research

Date to be Announced
Submit Proposal | Sponsor | Request More Info



Contact the Team:

TOPIC SUGGESTIONS:

Marina Filshtinsky
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: 617 276 5018
Email: mfilshtinsky@healthtech.com

PARTNERING AND SPONSORSHIP:

Companies A-K

Carolyn Cooke
Manager, Business Development
Phone: 781-972-5412
Email: ccooke@healthtech.com

Companies L-Z

Rod Eymael
Manager, Business Development
Phone: 781-247-6286
Email: reymael@healthtech.com

MEDIA AND ASSOCIATION:

Daniel Miller
Marketing Manager
Cambridge Healthtech Institute
Phone: 781-972-5492
Email: dmiller@healthtech.com

Hilary DuBois
Marketing Manager
Cambridge Healthtech Institute
Phone: 781-247-6287
Email: hdubois@healthtech.com